Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 2/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.39 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | PELI1 | Q96FA3 | 3/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | NMT1 | P30419 | 1/20 | 0.30 |
| ▸ | PLAU | P00749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1630761 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL2486077 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL277483 | 0.87 | — | — | |
| SCHEMBL15449450 | 0.87 | — | — | |
| SCHEMBL2166225 | 0.87 | — | — | |
| SCHEMBL178479 | 0.87 | — | — | |
| SCHEMBL5175963 | 0.85 | — | — | |
| SCHEMBL381340 | 0.85 | — | — | |
| SCHEMBL22820901 | 0.85 | CHRNB2 (0.38) | CHRNB2CHRNB4CHRNA3CHRNA4PARP1 | |
| SCHEMBL3706453 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3957732-A | ALTERNATING COPOLYMERS HAVING FUNCTIONAL GROUP AND PROCESS FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-05-18 | — | — | US | claimed |
| EP-3983462-B1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2025-01-08 | — | — | EP | disclosed |
| US-20220306791-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2022-09-29 | — | — | US | disclosed |
| US-11427728-B2 | Method for producing aqueous dispersions | BASF SE (DE) | 2022-08-30 | — | — | US | disclosed |
| EP-3983462-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2022-04-20 | — | — | EP | disclosed |
| US-11292861-B2 | Aqueous polymer dispersion | BASF SE (DE) | 2022-04-05 | — | — | US | disclosed |
| US-20210292457-A1 | AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2021-09-23 | — | — | US | disclosed |
| WO-2020249706-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | BASF SE (DE) | 2020-12-17 | — | — | WO | disclosed |
| EP-3491029-B1 | AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2020-05-20 | — | — | EP | disclosed |
| US-20190218414-A1 | METHOD FOR PRODUCING AQUEOUS DISPERSIONS | BASF SE (DE) | 2019-07-18 | — | — | US | disclosed |
| WO-2013174894-A1 | AQUEOUS BINDER COMPOSITIONS | BASF SE (DE) | 2013-11-28 | — | — | WO | disclosed |
| US-8329800-B2 | Binder compositions comprising boric acid or boric acid salt | BASF SE (DE) | 2012-12-11 | — | — | US | disclosed |
| US-20110312240-A1 | AQUEOUS BINDER COMPOSITIONS | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110257302-A1 | BINDER COMPOSITIONS COMPRISING BORIC ACID OR BORIC ACID SALT | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20110089020-A1 | Continuous Method for Producing Amides of Ethylenically Unsaturated Carboxylic Acids | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-04-21 | — | — | US | disclosed |
| US-6315926-B1 | HAZE-FREE | DSM N.V. (NL) | 2001-11-13 | — | — | US | disclosed |
| US-6068967-A | IN WHICH ONLY A DESIRED HYDROPHILIC COLLOID LAYER IS SELECTIVELY COLORED. | FUJI PHOTO FILM CO., LTD. (JP) | 2000-05-30 | — | — | US | disclosed |
| US-4190687-A | WITH COPOLYMER OF ETHYLENEICALLY UNSATURATED ESTER AND ETHYLENICALLY UNSATURATED HYDROCARBON TO PREVENT COLOR BLEEDING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-02-26 | — | — | US | disclosed |
| US-3964955-A | Bonding method using olefin-acrylic ester copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-06-22 | — | — | US | disclosed |
| US-3957732-A | ALTERNATING COPOLYMERS HAVING FUNCTIONAL GROUP AND PROCESS FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220306791-A1 | AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS | LPO, SORD, GYS1 | CHRNB2 4207/4885CHRNB4 4235/4885CHRNA3 4605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.